Pharmicell Cash Flow Quality Index
Pharmicell cash flow quality index. Pharmicell (005690) has a Cash Flow Quality Index of 1.00x as of September 2025. Operating cash flow of ₩8.78 Billion exceeds net income of ₩8.78 Billion, indicating high earnings quality where cash backs reported profits. See 005690 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Pharmicell (2019–2024)
Cash flow quality index of Pharmicell from 2019 to 2024. Historical Cash Flow Quality Index for Pharmicell across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Pharmicell (005690) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Pharmicell Cash Flow Quality Index by Year (2019–2024)
Pharmicell cash flow quality index by year from 2019 to 2024. Year-by-year earnings quality comparison for Pharmicell. For the full cash flow conversion analysis, see Pharmicell (005690) cash flow conversion.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | ₩3.50 Billion | ₩6.33 Billion | ▼ -83.3% |
| 2023 | 3.30x | ₩11.81 Billion | ₩3.58 Billion | ▲ +244.7% |
| 2022 | 0.96x | ₩7.91 Billion | ₩8.26 Billion | ▲ +273.4% |
| 2021 | -0.55x | ₩-5.22 Billion | ₩9.45 Billion | ▼ -132.3% |
| 2020 | 1.71x | ₩8.98 Billion | ₩5.24 Billion | ▲ +9962.0% |
| 2019 | -0.02x | ₩-75.50 Million | ₩4.35 Billion | — |